SpectraCure AB (2OK)
XFRA XFRA Primary Summary
SpectraCure AB (2OK) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has SpectraCure AB ever had a stock split?
SpectraCure AB Profile
| Health Care Technology Industry | Healthcare Sector | Dr. Masoud Khayyami Ph.D. CEO | XFRA Exchange | SE0007158118 ISIN |
| Sweden Country | 16 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
SpectraCure AB (publ) is a pioneering entity in the medical field, specifically focused on innovating cancer treatment systems since its inception in 2003. Based in the scientifically vibrant city of Lund, Sweden, the corporation stands at the forefront of technological advances in cancer therapy. Its fundamental objective revolves around the development and enhancement of treatment modalities for one of the most challenging diseases to manage - cancer. By leveraging advanced technology and research, SpectraCure aims to provide new, effective treatment solutions that can significantly improve patient outcomes.
Products and Services
- Q-PRO Laser Device
This advanced laser device is a quintessential component of SpectraCure’s innovative approach to cancer treatment. Designed with precision and efficiency in mind, the Q-PRO laser device operates as part of an interstitial photodynamic therapy system. Its application in treating cancers showcases SpectraCure’s commitment to providing cutting-edge solutions to medical challenges.
- IDOSE Software
Accompanying the Q-PRO laser device, the IDOSE software represents a breakthrough in treatment personalization and optimization. This software is integral to the effective administration of interstitial photodynamic therapy, particularly in the context of prostate cancer. By facilitating precise control and monitoring of the therapy, IDOSE ensures that treatment is not only effective but also tailored to the specific needs of each patient.
